Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Jiangsu Vcare Files NDA for Vicagrel Capsules with US FDA 2024-01-04 21:05
Avenzo Therapeutics Announces Global License of AVZO-021 (ARTS-021), a Potentially Best-in-Class Clinical Stage CDK2 Inhibitor from Allorion Therapeutics 2024-01-04 21:02
GenScript, GenScript ProBio, and Legend Biotech Will Attend the 42nd JPM Healthcare Conference, Advancing Innovation and Development in the Healthcare Sector 2024-01-04 17:37
GenScript Biotech Global Forum 2024 to Commence, Infusing New Vitality into the GCT Industry 2024-01-04 16:55
Laekna Announces Poster Presentation on Internally-Discovered Antibody for NASH/Liver Fibrosis at NASH-TAG 2024 2024-01-04 12:40
Telix to Present at the 42nd Annual J.P. Morgan Healthcare Conference 2024-01-04 06:20
IASO BIO Announces New Development Partnership with Umoja Biopharma to Develop Ex Vivo and In Vivo Cell and Gene Therapies 2024-01-04 05:30
GPN Vaccines Reports Positive Safety and Immunogenicity Data from its Phase 1 Trial of Gamma-PN 2024-01-04 04:30
Turn Biotechnologies' Expanded eTurna™ Delivery Platform Designed to Solve Delivery and Targeting Issues that Challenge Industry 2024-01-03 22:00
Mr. Chong-Yoon Lim, Chairman of COREE Group emphasizes "Creative destruction and Healthcare 4.0" [New Year Message at X-Twitter SNS] 2024-01-03 22:00
Brii Biosciences Appoints Dr. Brian Alvin Johns as Chief Scientific Officer 2024-01-03 20:00
Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases 2024-01-03 19:37
Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial for Hemophilia A 2024-01-03 18:10
Artificial Intelligence helps predict falls, creating safety system for patients 2024-01-03 16:00
Guo Guangchang's New Year's Message: Steer Through the Rapids, Believe in the Future 2024-01-03 11:35
Bangkok Dusit Medical Services strengthens partnership with CNN focusing on global health issues and solutions 2024-01-03 11:30
Sciwind Biosciences Announces Positive Topline Results from Phase 3 Clinical Trial of Ecnoglutide (XW003), a Long-acting cAMP Signaling Biased GLP-1 Analog, in Adult Patients with Type 2 Diabetes in China 2024-01-03 10:00
WuXi XDC Enters into Partnership Agreement with IntoCell, Enabling Clients to Accelerate ADC Discovery and Development 2024-01-03 09:28
USANA Named No. 1 Vitamins and Dietary Supplements Brand in Philippines 2024-01-03 09:07
Meihua International Medical Technologies Co., Ltd. Announces Closing of Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering 2024-01-03 06:19
1 56 57 58 59 60 1534